Literature DB >> 27481362

Effects of management in gestational diabetes mellitus with normal prepregnancy body mass index on pregnancy outcomes and placental ultrastructures: a prospective cohort study.

Yun Han1, Yan-Li Zheng2, Ai-Min Wu1, Hong-Bin Liu3, Jian-Bin Su4, Xiao-Yan Lu1, Yu-Wen Han1, Jin-Long Ji1, Ju-Hua Ji5, Yue Shi6.   

Abstract

A great quantity of gestational diabetes mellitus with normal prepregnancy body mass index have emerged with the new criteria of gestational diabetes mellitus in China based on the International Diabetes in Pregnancy Consensus group criteria, and understanding placental changes and how they affect outcomes are necessary in order to develop effective management approach. The aim of this study was to prospectively explore the effect of active management starting from the late second trimester in gestational diabetes mellitus women with normal prepregnancy body mass index on pregnancy outcomes and placental ultrastructures, and to provide scientific evidences for optimizing the management of gestational diabetes mellitus in China. Gestational diabetes mellitus women with normal prepregnancy body mass index in the same period of this prospective cohort study were divided into intervention group (n = 51) and control group (n = 55). The intervention group was managed rigorously, while the control group received conventional prenatal cares. The glucose profile, gestational weight gain and pregnancy outcomes were followed up and placental ultrastructures were observed and recorded by transmission electron microscopy. The blood glucose level and gestational weight gain in intervention group were significantly better controlled than those in control group (P < 0.01). The incidences of fetal distress, cesarean section and large for gestational age were significantly lower in intervention group than in control group (P < 0.05). There was a significant reduction in the incidence of abnormal placental ultrastructure in the intervention group (P < 0.01). After adjustment for confounding factors, the undesirable glycemic control and conventional management were related to abnormal placental ultrastructure (P < 0.05). Meanwhile, the undesirable glycemic control, abnormal placental ultrastructure and conventional management made sense in the incidence of fetal distress (P < 0.05), and the target glycemic control, recommend weight gain and active management were associated with reductions in the prevalence of cesarean delivery and large for gestational age (P < 0.05). The active management of gestational diabetes mellitus women with normal prepregnancy body mass index can improve pregnancy outcomes and placental ultrastructures, and the abnormal placental ultrastructure might be closely associated with the undesirable glycemic control and adverse pregnancy outcomes.

Entities:  

Keywords:  Gestational diabetes mellitus; Management; Placenta; Pregnancy outcome; Ultrastructure

Mesh:

Year:  2016        PMID: 27481362     DOI: 10.1007/s12020-016-1064-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

1.  Prepregnancy body mass index and dietary intake in the first trimester of pregnancy.

Authors:  E Derbyshire; J Davies; V Costarelli; P Dettmar
Journal:  J Hum Nutr Diet       Date:  2006-08       Impact factor: 3.089

2.  Diagnostic criteria for gestational diabetes mellitus (WS 331-2011).

Authors:  Hui-xia Yang
Journal:  Chin Med J (Engl)       Date:  2012-04       Impact factor: 2.628

3.  Placental weight relative to birthweight in pregnancies with maternal diabetes mellitus.

Authors:  Ellen M Strøm-Roum; Camilla Haavaldsen; Tom G Tanbo; Anne Eskild
Journal:  Acta Obstet Gynecol Scand       Date:  2013-03-09       Impact factor: 3.636

4.  Effect of prepregnancy body mass index categories on obstetrical and neonatal outcomes.

Authors:  Haim A Abenhaim; Robert A Kinch; Lucie Morin; Alice Benjamin; Robert Usher
Journal:  Arch Gynecol Obstet       Date:  2006-09-12       Impact factor: 2.344

5.  Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a randomized clinical trial.

Authors:  M Bonomo; D Corica; E Mion; D Gonçalves; G Motta; R Merati; A Ragusa; A Morabito
Journal:  Diabet Med       Date:  2005-11       Impact factor: 4.359

6.  The proceedings of the diabetes in pregnancy study group of North America 2009 conference.

Authors:  Oded Langer; Menachem Miodovnik; E Albert Reece; Barak M Rosenn
Journal:  J Matern Fetal Neonatal Med       Date:  2010-03

7.  Histological changes in placental syncytiotrophoblasts of poorly controlled gestational diabetic patients.

Authors:  M S al-Okail; O S al-Attas
Journal:  Endocr J       Date:  1994-08       Impact factor: 2.349

8.  Changes in prepregnancy body mass index between the first and second pregnancies and risk of large-for-gestational-age birth.

Authors:  Darios Getahun; Cande V Ananth; Morgan R Peltier; Hamisu M Salihu; William E Scorza
Journal:  Am J Obstet Gynecol       Date:  2007-06       Impact factor: 8.661

9.  Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in china.

Authors:  Wei-Wei Zhu; Hui-Xia Yang; Yu-Mei Wei; Jie Yan; Zi-Lian Wang; Xue-Lan Li; Hai-Rong Wu; Nan Li; Mei-Hua Zhang; Xing-Hui Liu; Hua Zhang; Yun-Hui Wang; Jian-Min Niu; Yu-Jie Gan; Li-Ruo Zhong; Yun-Feng Wang; Anil Kapur
Journal:  Diabetes Care       Date:  2012-11-27       Impact factor: 19.112

10.  Contribution of prepregnancy body mass index and gestational weight gain to caesarean birth in Canada.

Authors:  Susie Dzakpasu; John Fahey; Russell S Kirby; Suzanne C Tough; Beverley Chalmers; Maureen I Heaman; Sharon Bartholomew; Anne Biringer; Elizabeth K Darling; Lily S Lee; Sarah D McDonald
Journal:  BMC Pregnancy Childbirth       Date:  2014-03-18       Impact factor: 3.007

View more
  1 in total

Review 1.  Placental structural abnormalities in gestational diabetes and when they develop: A scoping review.

Authors:  Erin Ehlers; Omonseigho O Talton; Danny J Schust; Laura C Schulz
Journal:  Placenta       Date:  2021-04-26       Impact factor: 3.287

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.